Showing 1 - 7 results of 7 for search 'Alain Luxembourg', query time: 0.05s Refine Results
  1. 1
    9-Valent human papillomavirus vaccine: a review of the clinical development program

    9-Valent human papillomavirus vaccine: a review of the clinical development program by Alain Luxembourg, Erin Moeller

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial

    Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial by Vu Dinh Thiem, Nguyen Dang Quang, Nguyen Hai Tuan, Kyeongmi Cheon, Nancy Gallagher, Alain Luxembourg, Thomas Group, Cyrus Badshah

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women

    Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women by Susanne K. Kjaer, Thea E. Hetland Falkenthal, Karin Sundström, Christian Munk, Tina Sture, Oliver Bautista, Sonali Rawat, Alain Luxembourg

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine

    Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine by Ana Maria Guevara, Eugenio Suarez, Alejandro Victoria, Hextan YS Ngan, Angelica Lindén Hirschberg, Edison Fedrizzi, Oliver Bautista, Christine Shields, Amita Joshi, Alain Luxembourg

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants

    Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants by Suzanne M. Garland, Manjula Anagani, Neerja Bhatla, Sukanta Chatterjee, Sanjay Lalwani, Cecil Ross, Thomas Group, Jianxin Lin, Alain Luxembourg, Anuj Walia, Yingmei Tu

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

    Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up by Susanne K. Kjaer, Mari Nygård, Karin Sundström, Christian Munk, Sophie Berger, Mensur Dzabic, Katrin Elisabeth Fridrich, Marianne Waldstrøm, Sveinung Wergeland Sørbye, Oliver Bautista, Thomas Group, Alain Luxembourg

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years

    Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years by Ivette Maldonado, Manuel Plata, Mauricio Gonzalez, Alfonso Correa, Claudia Nossa, Anna R. Giuliano, Elmar A. Joura, Alex Ferenczy, Brigitte M. Ronnett, Mark H. Stoler, Hao Jin Zhou, Amita Joshi, Rituparna Das, Oliver Bautista, Thomas Group, Alain Luxembourg, Alfred Saah, Ulrike Kirsten Buchwald

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: